跳至主要内容
临床试验/NCT05110404
NCT05110404已完成不适用

EFFECT OF HIGH VERSUS LOW-VOLUME HIGH INTENSITY INTERVAL TRAINING ON GLYCEMIC AND LIPIDS CONTROL IN TYPE 2 DIABETES

Cairo University1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2021年12月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
72
试验地点
1
主要终点
fasting & 2-h post prandial blood glucose

研究概览

简要总结

Recently, HIIT has been recommended by the American diabetes association for type 2 diabetes. The high-volume HIIT has been studied extensively in patients with type 2 diabetes, however, little is known about the effectiveness of low-volume HIIT regarding target glycemic or lipid control in these patients. Therefore, the purpose of this study is to compare between two subtypes of HIIT (i.e. the low-volume HIIT versus the high-volume HIIT) with respect to exercise-induced changes in blood glucose, lipid profile and anthropometry in patients with type 2 diabetes mellitus. Statement of the Problem Is there any difference between the effect of high-volume and the low-volume high intensity interval training on glycemic and lipids control in type 2 diabetes?

Purpose of the study:

To assess the effect of the high-volume versus the low-volume high intensity interval training on glycemic and blood lipids control in type 2 diabetes.

Null Hypothesis:

There will be no difference between the effect of the high-volume versus the low-volume high intensity interval training on glycemic and blood lipids control in type 2 diabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Type II diabetes mellitus diagnosed by a physician as having HbA 1c of > 6.5%.
  • An established diagnosis of T2DM for at least 1year and less than 5 years.
  • Women patients.
  • Age between 35 to 45 years old.
  • Systolic Blood pressure less than or equal 130 mmHg.
  • Obese patients (BMI is between 30 and 39.9 kg/m 2 )
  • Patients with HbA 1c of 7-9%.
  • A self-reported sedentary lifestyle.
  • Patients receiving oral hypoglycemic medications described by the physician
  • Patients with hyperlipidemia.

排除标准

  • Patients with Cardiac diseases.
  • Patients with glaucoma.
  • Patients with diabetic complications (Diabetic foot, retinopathy, nephropathy, and diabetic peripheral neuropathy).
  • Musculoskeletal or neurological limitations to physical exercise.
  • Patients under insulin therapy
  • Patients with poorly controlled DM (HbA1c > 9%)
  • Bronchial asthma and chronic obstructive pulmonary disease.
  • Morbidly obese BMI ≥ 40 kg/m 2
  • Systolic Blood pressure more than 130 mmHg.
  • Anemia ( hemoglobin < 12 g/dL)
  • Osteopenia.

结局指标

主要结局

fasting & 2-h post prandial blood glucose

时间窗: 12 weeks

change in fasting \& 2-h post prandial blood glucose

body mass index

时间窗: 12 weeks

change in body mass index

waist circumference

时间窗: 12 weeks

change in waist circumference

waist/hip ratio

时间窗: 12 weeks

change in waist/hip ratio

Systolic and diastolic blood pressure

时间窗: 12 weeks

change in Systolic and diastolic blood pressure

HbA1c

时间窗: 12 weeks

change in HbA1c

fasting lipid profile

时间窗: 12 weeks

change in fasting lipid profile

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Asmaa Mohamed Mahmoud Mohamed

physiotherapist holds a master's degree in Physical therapy for Cardiovascular, Respiratory disorders and geriatrics, Faculty of physical therapy, Cairo university.

Cairo University

研究点 (1)

Loading locations...

相似试验